Evaluation and comparison of the diagnostic performance of routine blood tests in predicting liver fibrosis in chronic hepatitis B infection

References

• World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. 2015; Cited 2018 Mar 12. http://apps.who.int/iris/bitstream/10665/154590/1/9789241549059_eng.pdf?ua=1&ua=1
   Google Scholar
• European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370–398.
   PubMedGoogle Scholar
• Friedrich-Rust M, Poynard T, Castera L. Critical comparison of elastography methods to assess chronic liver disease. Nat Rev Gastroenterol Hepatol. 2016;13:402–411.
   PubMed Web of Science ®Google Scholar
• Yu JH, Lee JI. Current role of transient elastography in the management of chronic hepatitis B patients. Ultrasonography. 2017;36:86–94.
   PubMed Web of Science ®Google Scholar
• Dong XQ, Wu Z, Zhao H, et al. Evaluation and comparison of thirty noninvasive models for diagnosing liver fibrosis in chinese hepatitis B patients. J Viral Hepat. 2018;26:297–307.
   PubMed Web of Science ®Google Scholar
• Dong M, Wu J, Yu X, et al. Validation and comparison of seventeen noninvasive models for evaluating liver fibrosis in Chinese hepatitis B patients. Liver Int. 2018;38:1562–1570.
   PubMed Web of Science ®Google Scholar
• Rk S, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43:1317–1325.
   PubMed Web of Science ®Google Scholar
• Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518–526.
   PubMed Web of Science ®Google Scholar
• Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 2007;46:32–36.
   PubMed Web of Science ®Google Scholar
• Lin ZH, Xin YN, Dong QJ, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53:726–736.
   PubMed Web of Science ®Google Scholar
• Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology. 2015;61:292–302.
   PubMed Web of Science ®Google Scholar
• Desalegn H, Aberra H, Berhe N, et al. Are non-invasive fibrosis markers for chronic hepatitis B reliable in Sub-Saharan Africa? Liver Int. 2017;37:1461–1467.
   PubMed Web of Science ®Google Scholar
• Wu X, Cai B, Su Z, et al. Aspartate transaminase to platelet ratio index and gamma-glutamyl transpeptidase-to-platelet ratio outweigh fibrosis index based on four factors and red cell distribution width-platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepatitis B. J Clin Lab Anal. 2018;32:e22341.
   PubMed Web of Science ®Google Scholar
• Lemoine M, Shimakawa Y, Nayagam S, et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut. 2016;65:1369–1376.
   PubMed Web of Science ®Google Scholar
• Zhang W, Sun M, Chen G, et al. Reassessment of gamma-glutamyl transpeptidase to platelet ratio (GPR): a large-sample, dynamic study based on liver biopsy in a Chinese population with chronic hepatitis B virus (HBV) infection. Gut. 2018;67:989–991.
   PubMed Web of Science ®Google Scholar
• Li Q, Li W, Huang Y, et al. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China. J Viral Hepat. 2016;23:912–919.
   PubMed Web of Science ®Google Scholar
• Chen B, Ye B, Zhang J, et al. RDW to platelet ratio: a novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B. Plos One. 2013;8:e68780.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Liu J, Wang J, et al. Platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) are associated with chronic hepatitis B virus (HBV) infection. Int Immunopharmacol. 2017;5:1–8.
   Google Scholar
• Liu C, Jia BS, Zou BW, et al. Neutrophil-to-lymphocyte and aspartate-to-alanine aminotransferase ratios predict hepatocellular carcinoma prognosis after transarterial embolization. Medicine. 2017;96:e8512.
   PubMed Web of Science ®Google Scholar
• Li Y, Huang YS, Wang ZZ, et al. Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B. Aliment Pharmacol Ther. 2016;43:458–469.
   PubMed Web of Science ®Google Scholar
• Lee J, Kim MY, Kang SH, et al. The gamma-glutamyl transferase to platelet ratio and the FIB-4 score are noninvasive markers to determine the severity of liver fibrosis in chronic hepatitis B infection. Br J Biomed Sci. 2018;75:128–132.
   PubMed Web of Science ®Google Scholar
• Kennedy P, Wagner M, Castera L, et al. Quantitative elastography methods in liver disease: current evidence and future directions. Radiology. 2018;286:738–763.
   PubMed Web of Science ®Google Scholar
• Conti F, Serra C, Vukotic R, et al. Assessment of liver fibrosis with elastography point quantification vs other noninvasive methods. Clin Gastroenterol Hepatol. 2019;17:510–517.
   PubMed Web of Science ®Google Scholar
• Ren T, Wang H, Wu R, et al. Gamma-glutamyl transpeptidase-to-platelet ratio predicts significant liver fibrosis of chronic hepatitis B patients in China. Gastroenterol Res Pract. 2017;2017:7089702.
   PubMedGoogle Scholar
• Wu D, Rao Q, Chen W, et al. Development and validation of a novel score for fibrosis staging in patients with chronic hepatitis B. Liver Int. 2018;38:1930–1939.
   PubMed Web of Science ®Google Scholar
• Wang RQ, Zhang QS, Zhao SX, et al. Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients. J Int Med Res. 2016;44:1302–1313.
   PubMed Web of Science ®Google Scholar
• Li Q, Song J, Huang Y, et al. The gamma-glutamyl-transpeptidase to platelet ratio does not show advantages than APRI and FIB-4 in diagnosing significant fibrosis and cirrhosis in patients with chronic hepatitis B. Medicine. 2016;95:e3372.
   PubMed Web of Science ®Google Scholar
• Huang R, Wang G, Tian C, et al. Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI, FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China. Sci Rep. 2017;7:8543.
   PubMed Web of Science ®Google Scholar
• Peng Y, Li Y, He Y, et al. The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review. Expert Rev Gastroenterol Hepatol. 2018;12:503–513.
   PubMed Web of Science ®Google Scholar
• Celikbilek M, Dogan S, Gursoy S, et al. Noninvasive assessment of liver damage in chronic hepatitis B. World J Hepatol. 2013;5:439–445.
   PubMedGoogle Scholar
• Chon YE, Choi EH, Song KJ, et al. Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis. Plos One. 2012;7:e44930.
   PubMed Web of Science ®Google Scholar
• Zeng J, Zheng J, Huang Z, et al. Comparison of 2-D shear wave elastography and transient elastography for assessing liver fibrosis in chronic hepatitis B. Ultrasound Med Biol. 2017;43:1563–1570.
   PubMed Web of Science ®Google Scholar
• European Association for Study of Liver, Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63:237–264.
   PubMed Web of Science ®Google Scholar